PASADENA, Calif.--(BUSINESS WIRE)--Holoclara, a biotechnology company pioneering the development of worm-derived therapies for allergic and autoimmune disorders, today announced the launch of a ...

In 2006, a contested region of southern Sudan that had been embroiled in a long civil war recorded more than 20,000 cases of Guinea worm disease, 80% of the world’s total. Last year, the now ...